Hepatokine levels during the first or early second trimester of pregnancy and the subsequent risk of gestational diabetes mellitus: a systematic review and meta-analysis

References

• Abdullah, B., et al., 2012. Serum angiopoietin-related growth factor (AGF) levels are elevated in gestational diabetes mellitus and associated with insulin resistance. Ginekologia polska, 83 (10), 749–753.
   PubMed Web of Science ®Google Scholar
• Abdul-Wahed, A., et al., 2014. A link between hepatic glucose production and peripheral energy metabolism via hepatokines. Molecular metabolism, 3 (5), 531–543.
   PubMed Web of Science ®Google Scholar
• Agarwal, M.M., Punnose, J., and Dhatt, G.S., 2004. Gestational diabetes: problems associated with the oral glucose tolerance test. Diabetes research and clinical practice, 63 (1), 73–74.
   PubMed Web of Science ®Google Scholar
• Barahona, M.J., et al., 2005. Period of gestational diabetes mellitus diagnosis and maternal and fetal morbidity. Acta obstetricia et gynecologica scandinavica, 84 (7), 622–627.
   PubMed Web of Science ®Google Scholar
• Bartha, J.L., Martinez-DEL-Fresno, P., and Comino-Delgado, R., 2003. Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications. European journal of obstetrics & gynecology and reproductive biology, 109 (1), 41–44.
   PubMed Web of Science ®Google Scholar
• Beigi, A., et al., 2015. Association between serum adropin levels and gestational diabetes mellitus; a case-control study. Gynecological endocrinology, 31 (12), 939–941.
   PubMed Web of Science ®Google Scholar
• Bobbert, T., et al., 2013. Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes care, 36 (1), 145–149.
   PubMed Web of Science ®Google Scholar
• Bonakdaran, S., Khorasani, Z.M., and Jafarzadeh, F., 2017. Increased serum level of FGF21 in gestational diabetes mellitus. Acta endocrinologica (bucharest), 13 (3), 278–281.
   PubMed Web of Science ®Google Scholar
• Catalano, P.M., et al., 1993. Reproducibility of the oral glucose tolerance test in pregnant women. American journal of obstetrics and gynecology, 169 (4), 874–881.
   PubMed Web of Science ®Google Scholar
• Catalano, P.M., et al., 1993. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. The American journal of physiology, 264 (1 Pt 1), E60–E67.
   PubMed Web of Science ®Google Scholar
• Celik, E., et al., 2013. Maternal and fetal adropin levels in gestational diabetes mellitus. Journal of perinatal medicine, 41 (4), 375–380.
   PubMed Web of Science ®Google Scholar
• Chen, H., et al., 2012. Low serum levels of the innate immune component ficolin-3 is associated with insulin resistance and predicts the development of type 2 diabetes. Journal of molecular cell biology, 4 (4), 256–257.
   PubMed Web of Science ®Google Scholar
• Crowther, C.A., et al., 2005. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England journal of medicine, 352 (24), 2477–2486.
   PubMed Web of Science ®Google Scholar
• Dąbrowski, F.A., et al., 2016. First and third trimester serum concentrations of adropin and copeptin in gestational diabetes mellitus and normal pregnancy. Ginekologia polska, 87 (9), 629–634.
   PubMed Web of Science ®Google Scholar
• Dekker, N.M., et al., 2014. Increased placental expression of fibroblast growth factor 21 in gestational diabetes mellitus. Journal of clinical endocrinology and metabolism., 99 (4), E591–8.
   PubMed Web of Science ®Google Scholar
• Dieplinger, H., and Dieplinger, B., 2015. Afamin-A pleiotropic glycoprotein involved in various disease states. Clinica chimica acta, 446, 105–110.
   PubMed Web of Science ®Google Scholar
• Dieplinger, B., et al., 2013. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clinica chimica acta, 425, 236–241.
   PubMed Web of Science ®Google Scholar
• Ebert, T., et al., 2009. Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism, 58 (4), 547–551.
   PubMed Web of Science ®Google Scholar
• Egger, M., et al., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ (clinical research ed.), 315 (7109), 629–634.
   PubMed Web of Science ®Google Scholar
• Farhan, S., et al., 2012. Fetuin-A characteristics during and after pregnancy: result from a case control pilot study. International journal of endocrinology, 2012, 1–5.
   Web of Science ®Google Scholar
• Flyvbjerg, A., 2010. Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. Nature reviews. Endocrinology, 6 (2), 94–101.
   PubMed Web of Science ®Google Scholar
• Ghosh, P., et al., 2015. Role of complement and complement regulatory proteins in the complications of diabetes. Endocrine reviews, 36 (3), 272–288.
   PubMed Web of Science ®Google Scholar
• Higgins, J.P., et al., 2003. Measuring inconsistency in meta-analyses. BMJ (clinical research ed.), 327 (7414), 557–560.
   PubMed Web of Science ®Google Scholar
• Hillier, T.A., et al., 2007. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes care, 30 (9), 2287–2292.
   PubMed Web of Science ®Google Scholar
• Houstis, N., Rosen, E.D., and Lander, E.S., 2006. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440 (7086), 944–948.
   PubMed Web of Science ®Google Scholar
• Hozo, S.P., Djulbegovic, B., and Hozo, I., 2005. Estimating the mean and variance from the median, range, and the size of a sample. BMC medical research methodology, 5, 13.
   PubMedGoogle Scholar
• Hubalek, M., et al., 2014. The vitamin E-binding protein afamin increases in maternal serum during pregnancy. Clinica chimica acta , 434 (100), 41–47.
   PubMed Web of Science ®Google Scholar
• Iyidir, O.T., et al., 2015. Serum levels of fetuin A are increased in women with gestational diabetes mellitus. Archives of gynecology and obstetrics, 291 (4), 933–937.
   PubMed Web of Science ®Google Scholar
• Kampmann, F.B., et al., 2019. Increased leptin, decreased adiponectin and FGF21 concentrations in adolescent offspring of women with gestational diabetes. European journal of endocrinology, 181 (6), 691–700.
   PubMed Web of Science ®Google Scholar
• Kansu-Celik, H., et al., 2019. Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels. Archives of endocrinology and metabolism, 63 (2), 121–127.
   PubMed Web of Science ®Google Scholar
• Kollerits, B., et al., 2017. Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: a pooled analysis in more than 20,000 individuals. Diabetes care, 40 (10), 1386–1393.
   PubMed Web of Science ®Google Scholar
• Köninger, A., et al., 2014. Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome. Endocrine connections, 3 (3), 120–126.
   PubMed Web of Science ®Google Scholar
• Köninger, A., et al., 2019. Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally. Endocrine connections, 8 (5), 616–624.
   PubMed Web of Science ®Google Scholar
• Köninger, A., et al., 2018. Is afamin a novel biomarker for gestational diabetes mellitus? A pilot study. Reproductive biology and endocrinology, 16 (1), 30.
   PubMed Web of Science ®Google Scholar
• Kralisch, S., et al., 2017. Regulation of the novel adipokines/hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metabolism, 68, 88–94.
   PubMed Web of Science ®Google Scholar
• Kronenberg, F., et al., 2014. Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circulation: cardiovascular genetics, 7 (6), 822–829.
   PubMedGoogle Scholar
• Landon, M.B., et al., 2009. A multicenter, randomized trial of treatment for mild gestational diabetes. The New England journal of medicine, 361 (14), 1339–1348.
   PubMed Web of Science ®Google Scholar
• Lee, S.M., et al., 2019. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia, 62 (2), 238–248.
   PubMed Web of Science ®Google Scholar
• Li, S.M., et al., 2015. Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum. Endocrine, 48 (2), 519–527.
   PubMed Web of Science ®Google Scholar
• Megia, A., et al., 2015. Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth. Acta diabetologica, 52 (4), 693–700.
   PubMed Web of Science ®Google Scholar
• Metzger, B.E., et al., 2010. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care, 33 (7), e98–82.
   PubMed Web of Science ®Google Scholar
• Misu, H., et al., 2010. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell metabolism, 12 (5), 483–495.
   PubMed Web of Science ®Google Scholar
• Mita, Y., et al., 2017. Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models. Nature communications, 8 (1), 1658.
   PubMed Web of Science ®Google Scholar
• Oike, Y., et al., 2005. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nature medicine, 11 (4), 400–408.
   PubMed Web of Science ®Google Scholar
• Ortega-Senovilla, H., et al., 2013. Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased neonatal fat mass in pregnant women with gestational diabetes mellitus. The journal of clinical endocrinology and metabolism, 98 (8), 3430–3437.
   PubMed Web of Science ®Google Scholar
• Pinnaduwage, L., et al., 2018. Changes over time in hepatic markers predict changes in insulin sensitivity, β-cell function, and glycemia. The journal of clinical endocrinology & metabolism, 103 (7), 2651–2659.
   PubMed Web of Science ®Google Scholar
• Popova, P., et al., 2018. A randomised, controlled study of different glycaemic targets during gestational diabetes treatment: effect on the level of adipokines in cord blood and ANGPTL4 expression in human umbilical vein endothelial cells. International journal of endocrinology, 2018, 1–8.
   Web of Science ®Google Scholar
• Ravnsborg, T., et al., 2019. First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus. PLoS one, 14 (3), e0214457
   PubMed Web of Science ®Google Scholar
• Rottenkolber, M., et al., 2015. The diabetes risk phenotype of young women with recent gestational diabetes. The journal of clinical endocrinology and metabolism, 100 (6), E910–E918.
   PubMed Web of Science ®Google Scholar
• Sabbagh, H.J., et al., 2015. Passive smoking in the etiology of non-syndromic orofacial clefts: a systematic review and meta-analysis. PLoS one, 10 (3), e0116963.
   PubMed Web of Science ®Google Scholar
• Saito, Y., 2020. Selenoprotein P as an in vivo redox regulator: disorders related to its deficiency and excess. Journal of clinical biochemistry and nutrition, 66 (1), 1–7.
   PubMed Web of Science ®Google Scholar
• Song, C., et al., 2016. Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials. Obesity reviews, 17 (10), 960–969.
   PubMed Web of Science ®Google Scholar
• Stang, A., 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology, 25 (9), 603–605.
   PubMed Web of Science ®Google Scholar
• Stein, S., et al., 2010. Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism: clinical and experimental, 59 (1), 33–37.
   PubMed Web of Science ®Google Scholar
• Swartz, M.K., 2011. The PRISMA statement: a guideline for systematic reviews and meta-analyses. Journal of pediatric health care, 25 (1), 1–2.
   PubMed Web of Science ®Google Scholar
• Syngelaki, A., et al., 2015. First-trimester screening for gestational diabetes mellitus based on maternal characteristics and history. Fetal diagnosis and therapy, 38 (1), 14–21.
   PubMed Web of Science ®Google Scholar
• Tan, B.K., et al., 2013. Lower cerebrospinal fluid/plasma fibroblast growth factor 21 (FGF21) ratios and placental FGF21 production in gestational diabetes. PLoS one, 8 (6), e65254.
   PubMed Web of Science ®Google Scholar
• Tariq, A., et al., 2018. AHSG rs4918 polymorphism poses a weak predisposition to insulin resistance during pregnancy. Journal of Pakistan medical association, 68 (5), 698–701.
   PubMed Web of Science ®Google Scholar
• Tieu, J., et al., 2017. Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health. The Cochrane database of systematic reviews, 8 (8), CD007222.
   PubMed Web of Science ®Google Scholar
• Topuz, M., et al., 2013. Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus. Journal of investigative medicine, 61 (8), 1161–1164.
   PubMed Web of Science ®Google Scholar
• Tramontana, A., et al., 2018a. First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women. Clinica chimica acta, 476, 160–166.
   PubMed Web of Science ®Google Scholar
• Tramontana, A., et al., 2018b. Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies. Placenta, 62, 9–15.
   PubMed Web of Science ®Google Scholar
• Voegele, A.F., et al., 2002. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry, 41 (49), 14532–14538.
   PubMed Web of Science ®Google Scholar
• Wang, W.J., et al., 2020. Fetuin-A and fetal growth in gestational diabetes mellitus. BMJ open diabetes research & care, 8 (1), e000864.
   PubMed Web of Science ®Google Scholar
• Wang, D., et al., 2013. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PLoS one, 8 (11), e81190.
   PubMed Web of Science ®Google Scholar
• WHO, 2014. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes research and clinical practice, 103 (3), 341–363.
   PubMed Web of Science ®Google Scholar
• Wexler, D.J., et al., 2018. Research gaps in gestational diabetes mellitus: executive summary of a national institute of diabetes and digestive and kidney diseases workshop. Obstetrics and gynecology, 132 (2), 496–505.
   PubMed Web of Science ®Google Scholar
• Xu, L., et al., 2013. Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, and inflammation in gestational diabetes mellitus. PLoS one, 8 (12), e81615.
   PubMed Web of Science ®Google Scholar
• Yuan, X.-S., et al., 2018a. Ficolin-3/adiponectin ratio for the prediction of gestational diabetes mellitus in pregnant women. Journal of diabetes investigation, 9 (2), 403–410.
   PubMed Web of Science ®Google Scholar
• Yuan, X-S., et al., 2018b. Increased secreted frizzled-related protein 4 and ficolin-3 levels in gestational diabetes mellitus women. Endocrine journal, 65 (4), 499–508.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2008. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes, 57 (5), 1246–1253.
   PubMed Web of Science ®Google Scholar